| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 55.6625 | 60 |
| GSM780708 | Untreated after 4 days (C2_1) | 51.1737 | 52 |
| GSM780709 | Untreated after 4 days (C3_1) | 55.2276 | 60 |
| GSM780719 | Untreated after 4 days (C1_2) | 60.3166 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.6594 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 54.3617 | 59 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 63.9463 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 60.8877 | 65 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.6487 | 62 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 68.6066 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 61.597 | 65 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 59.8369 | 64 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 56.296 | 61 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 62.0699 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.787 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.2593 | 49 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.4809 | 57 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 63.2692 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 78.9002 | 71 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.2128 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 57.9818 | 63 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 66.5638 | 68 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 65.5388 | 67 |